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ABSTRACT
Gestational Diabetes Mellitus (GDM) is associated with pregnancy complications, however its mechanism has not been 
fully understood. The aim of this study was to investigate the single nucleotide polymorphism (SNP) for identifying 
candidate genes involve in risk factors and complications of GDM. A total of 174 pregnant women with GDM and 114 
healthy pregnant women were genotyped with 384 SNPs from 236 genes. The SNPs identified were rs10946398 (CDKAL1) 
in GDM risk factors; rs328 (LPL) and rs1042778 (OXTR) in complications of caesarean section; rs5404 (SLC2A2), rs5400 
(SLC2A2) and rs13306465 (IRS1) for neonatal intensive care admission. Whereby SNPs rs12255372, rs7901695 and 
rs7903146 from TCF7L2 gene had six times higher risk (OR, 6.40-6.53) for T2DM at postpartum. In conclusion, although 
the above SNPs were identified with GDM risk factors and complications among pregnant Malaysian women with GDM, 
a larger study is needed to ascertain this candidate genes actual association.
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ABSTRAK
Diabetes Melitus Gestasi (GDM) mempunyai perkaitan dengan komplikasi kehamilan, namun demikian mekanismenya 
masih belum dikenal pasti sepenuhnya. Kajian ini adalah untuk mengkaji polimorfisme nukleotida tunggal (SNP) bagi 
mengenal pasti gen yang terlibat dalam faktor risiko GDM dan komplikasinya. Sejumlah 174 wanita hamil dengan GDM 
and 114 wanita hamil yang sihat telah digenotip dengan 384 SNPs daripada 236 gen. SNPs yang dikenal pasti adalah 
rs10946398 (CDKAL1) dalam faktor risiko GDM; rs328 (LPL) dan rs1042778 (OXTR) dalam komplikasi pembedahan 
caesarean; rs5404 (SLC2A2), rs5400 (SLC2A2) dan rs13306465 (IRS1) untuk kemasukan wad rawatan rapi neonatal. 
Sementara SNPs rs12255372, rs7901695 dan rs7903146 daripada gen TCF7L2 mempunyai enam kali lebih tinggi risiko 
(OR, 6.40-6.53) untuk T2DM semasa postpartum. Sebagai kesimpulan, walaupun SNPs di atas telah dikenal pasti dengan 
faktor risiko GDM dan komplikasinya dalam kalangan wanita Malaysia yang hamil dengan Diabetes Gestasi, satu kajian 
yang lebih besar adalah perlu bagi memastikan penglibatan sebenar gen tersebut.
Kata kunci: Diabetes melitus gestasi; komplikasi; polimorfisme nukleotida tunggal; risiko; Malaysia
INTRODUCTION
Globally Diabetes Mellitus (DM) is currently recognized 
as a ‘critical’ disease which is also witnessed in Malaysia. 
Among the Malaysian adults aged 30 years and above, with 
an increase of 80% over 10 years, the prevalence had arose 
from 8.3% in 1996 to 14.9% in 2006 (Letchuman et al. 
2010). The concern arises when this involves those women 
in the reproductive age. Gestational diabetes mellitus 
(GDM) is defined as carbohydrate intolerance that begins 
or first recognized during pregnancy. It is also known to 
be associated with maternal and fetal morbidities, however 
the comprehensive mechanisms are yet to be discovered. 
DM and GDM have similar pathophysiology and are proven 
worldwide to poses similar genetic susceptibility including 
among the Malaysian women (Nor Khatijah et al. 2011). 
They also have common predisposing risk factors to both 
diseases namely family history of diabetes, ethnicity 
preponderance and excessive body weight.
 The pregnancy complications include urinary 
tract infections, polyhydromnios, preeclampsia, 
fetal malformations, caesarean sections, postpartum 
haemorrhage, neonatal hypoglycemia, hyperbilirubinemia 
and an increased rate of infant’s admission to neonatal 
ward (Chris et al. 2003). Not only those known possible 
complications, it was also shown that those who are 
diagnosed earlier with GDM (before 20 weeks of gestation) 
has an increased need for insulin treatment during 
pregnancy and a higher risk of developing type 2 diabetes 
mellitus (T2DM) in six years’ time (Illka et al. 2006; Jens 
et al. 2001). Thus, it is equally important to know who 
among the pregnant mothers are more prone to GDM. 
These factors include clinical features of obesity, personal 
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history of GDM, glycosuria and a strong family history of 
diabetes (American Diabetes Association 2002). Early 
and thorough education about the effects of disorder on 
possible pregnancy complications and fetal problems are 
necessary. Complications of GDM are mostly preventable, if 
proper glycaemic control is implemented; based on dietary 
control, regular home glucose monitoring and judicious 
use of insulin therapy.
 Understanding of specific risks as well as their 
complex interactions could allow identifications of risk 
towards GDM and its complications with the aim to further 
strategize GDM’s management. Genetic variants in such 
genes are proven to increase the risk of DM in varied 
spectrum among various populations (Ramachandran et al. 
2010; Zeggini et al. 2008), diabetic complications in adults 
with DM (Eero et al. 2008) and association with lower birth 
weight in offspring with family history of type 1 diabetes 
mellitus (T1DM) (Christiane et al. 2009). 
 We highlighted the genetic variants to GDM (Nor 
Khatijah et al. 2011) where twelve T2DM SNPs were 
replicated in Malaysian population with GDM. Eight 
genes with their SNPs (CDKAL1 (rs7754840, rs10946398, 
rs9465871, rs7756992); CDKN2A/2B (rs108116610); 
FBXW7 (rs6823091); MS4A7 (rs7935082), OXTR (rs237889), 
TCF7L2 (rs7903146, rs7961581); TRIM27 (rs1016472); 
WNT5B (rs2270031) were involved with GDM. Thus, in 
this part of the study, further analysis of single nucleotide 
polymorphism (SNP) was performed to identify candidate 
genes that are involve in risk factors of GDM and its 
complications. 
MATERIAL AND METHODS
This study was approved by the Institutional Research and 
Ethics Board. It was performed in a tertiary centre over a 
period of 2 years (April 2007 till March 2009). This was 
the second part of the study with reanalysis of SNPs for 
different intention, using the same study sample that was 
published earlier (Nor Khatijah et al. 2011). Women with 
chronic diseases or multiple pregnancies were excluded 
from the study. Written informed consent was taken from 
the recruited patients. A GDM universal screening of a 
modified glucose tolerance test (MGTT) was done between 
16 and 28 weeks of gestation for all women with suitable 
criteria. They were fasted overnight before fasting venous 
blood glucose (FBS) level was taken in the morning. A 
75 g glucose drink was given and 2 h post prandial (2-
HPP) blood glucose was later taken. FBS values of 3.0-6.0 
mmol/l and 2-HPP below 7.8 mmol/l were considered to be 
normal. Any women exceeded this range were diagnosed 
with GDM. They were managed according to the hospital 
protocol. After 6 weeks post partum, a repeated MGTT tests 
were performed among GDM women to indicate glucose 
intolerance level after pregnancy. 
 Contributing risk factors including family history of 
diabetes, history of abnormal or macrosomia baby and 
glycosuria from the antenatal history were recorded. The 
pregnancy outcomes include maternal complications; uterus 
bigger than dates, polyhydromnion, preterm delivery, pre-
eclampsia, cesarean section and post-partum hemorrhagec 
were analysed. Fetal complications; macrosomia, anomaly, 
stillbirth and neonatal; hypoglycaemia, hyperbilirubinaemia, 
hypocalcemia, polycythaemia, birth trauma and neonatal 
intensive care unit (NICU) admission were documented. 
Demographic characteristics such as race, age, parity 
and maternal weight were analyzed. Controls were those 
women who were not diagnosed with GDM. 
 About 288 participants were included in the 
genotyping process, with 174 women with GDM and 
114 healthy controls. Extractions of DNA from 10 mls of 
maternal peripheral blood using salt extraction method 
were further analyzed using Illumina GoldenGate assay 
(Illumina, San Diego). The SNPs genotyping was performed 
in batches to detect 384 SNPs that were associated with 
gestational diabetes mellitus and T2DM. The samples 
of whole genome DNA were processed to be amplified, 
fragmented and hybridized. The specifically hybridized 
DNA fragments were labeled by a flourescent dye with a 
single base extension reaction. Non-specific fragments 
were eliminated. Later, the gene chips were imaged using 
BeadArray scanner (Illumina). Raw genotyping data were 
imported using BeadStudio Genotyping Module v3.0 
(Illumina, San Diego). Individual SNPs were analyzed 
and filtered based on SNPs call rate > 95%, minor allele 
frequency > 0.1 (using BeadStudio Genotyping Module 
v3.0) with no deviation from Hardy Weinberg equilibrium 
in both groups. Further disease marker association analysis 
was performed only on qualified SNPs as in our previous 
publication (Nor Khatijah et al. 2011).
 Descriptive statistics of categorical variables was 
reported by using frequency and percentages while the 
mean and SD was checked for numerical variables. Logistic 
regression was carried out to assess the relationship 
between the risk factors, complications and T2DM with 
single nucleotide polymorphism. The crude odds ratios 
were obtained and the significance P-values were set at 
0.05 (2-tailed). Data entry and analysis were done using 
SPSS for windows (version 15), produced by SPSS, Chicago, 
IL, USA.
 SNP & Variation Suite (SVS v7.0) was additional third 
party software with advance parameter testing applied to 
reveal SNP association mostly in genome wide association 
study (GWAs). Trend test was done through this software 
to determine association between polymorphism and 
disease trait in case control study under hypothesis of 
genetic models such as allelic model, dominant, recessive 
or additive. It was more conservative and did not rely on 
assumption of Hardy-Weinberg Equilibrium (HWE) in case 
and control study (Balding 2006). A trend analysis tested a 
linear trend of increasing effect across three groups GG, Gg 
and gg by coding them as 0, 1 or 2 in a logistic regression 
(Thakkinstian et al. 2009) and more stringent than Chi 
square and should be used in association testing. Further 
analysis was described in earlier part of this study (Nor 
Khatijah et al. 2011). The clinical features of risk factors 
and complications in GDM (n=174 women) and those 
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non GDM (n=114 women) were analysed with regards to 
possible SNPs and candidate genes identification. 
RESULTS
The demographic data of the participants were comparable 
and described in detailed during the first part of the study 
(Nor Khatijah et al. 2011). Among 174 women with 
GDM and 114 women of controls that were genotypically 
analysed, family history of diabetes mellitus was the 
highest risk predictor for GDM cases (55.2% in GDM 
versus 48.2% in controls) followed by glycosuria and size 
of uterus (Table 1). Caesarean section was higher than 
premature delivery (28.1% versus 17.5%, respectively), 
among complications that seemed likely to happen in GDM 
mothers. At 6 weeks post partum, 127 patients failed to 
carry out the MGTT and 3 were lost to follow up. For those 
who underwent the test, 30 patients were normal while 14 
were diagnosed with T2DM after delivery. Birth weights of 
the babies were comparable (3.09 ± 0.5 kg in GDM, 3.04 ± 
0.5 kg in normal) in both groups. However those with GDM 
mothers had more babies with macrosomia (6.4% in GDM 
versus 2.7% in controls), hyperbilirubinaemia (7.6% in 
GDM versus 3.6% in controls) with higher NICU admission 
(4.3% in GDM versus 3.6% in controls) (Table 1). 
 In genetic association analysis, there were SNPs 
discovered to be present in women with risk factors and 
GDM complications (Table 2). Among risk factors of GDM, 
CDKAL1 gene (rs10946398) was statistically significant 
present in those with family history of diabetes mellitus 
with a protective effect (OR=0.49). In GDM complications; 
rs328 and rs1042778 were present among women who had 
caesarean sections while rs5404, rs5400 and rs13306465 
were significant among cases who had their babies admitted 
to NICU (OR=2.25-6). The current study had also replicated 
the SNPs rs12255372, rs7901695 and rs7903146 (OR = 6.45, 
6.4, 6.53, respectively) in TCF7L2 gene among participants 
with occurrence of T2DM at six weeks postpartum. All the 
above SNPs are associated with T2DM and currently found 
to be present among those women with GDM risk factors 
or those with GDM complications.
DISCUSSION
A tremendous surge of Diabetes Mellitus prevalence 
throughout the world including Malaysia nowadays, 
has also affected those in the reproductive age resulting 
in increment in the prevalence of Gestational Diabetes 
Mellitus. As GDM is recognized with its genetic potential 
through transgenerational effect, it is timely to address the 
issue of its complication and to recognize its risk factors 
through genetic aspect before incurring a massive public 
health burden. 
 In this current study, women with family history of 
DM had the highest risk factor towards GDM as seen in a 
previous report (Ben-Haroush et al. 2004). Genetically 
the presence of CDKAL1 gene was detected here in those 
with family history of DM, was earlier identified as a 
susceptibility gene for T2DM among Europeans and 
Asians (Cho et al. 2009) and was also discovered in our 
GDM patients (Nor Khatijah et al. 2011). However, the 
current study showed rs10946398 in CDKAL1 gene with a 
negative association (OR < 1) when analysed against GDM 
risk factor (family history of DM). With family history 
of DM, perhaps earlier screening and intervention to life 
style may contribute to explain its protective effect. SNP 
rs10946398 in CDKAL1 gene was earlier reported as a CDK5 
regulatory subunit-associated protein 1-like 1 (Petry 2010). 
No association had been reported so far on family history 
of DM factor with CDKAL1 gene. Whether the presence of 
this SNP contributes or not to the actual clinical risk factor 
need to be verified further in a bigger scale study. 
 Caesarean section was seen more than premature 
delivery in our GDM mothers (Table 1). However 
Caesarean sections could be multifactorial. As reported 
in earlier part of the study (Nor Khatijah et al. 2011), this 
smaller complication probably could be explained with 
a mild diabetes to start off, with fasting blood glucose < 
5.3 mmol/l in our cohort of patients. Among these GDM 
women 83.9% were sufficed with diet modification only 
and the other 16.1% patients were given insulin injection 
in addition to the dietary control. Studies have shown 
that early treatment in this group of patients may result 
in the above (Landon et al. 2010; Nor Azlin et al. 2011). 
Studies (Tracy et al. 2005) have also proven that treatment 
reduces the rate of macrosomia, Caesarean section, fetal 
metabolic complications and neonatal intensive care unit 
days, as shown in Table 1. Among those women who had 
screening done at post partum, a third of them developed 
T2DM as previous studies had described (Ben-Haroush et 
al. 2004).
 Current findings suggested that there was a significant 
correlation between respective SNPs in LPL, OXTR, SLC2A2 
and IRS1 with caesarean sections and admittance to the NICU 
(Table 2). To the best of our knowledge, this has not been 
reported before with regards to GDM complications. The 
LPL gene which controls the lipid level in the bloodstream 
is reported to be involved in T2DM pathogenesis in the 
Korean population (Cho et al. 2009). A relationship 
between rs343 in LPL gene with T2DM-related phenotypes 
in total cholesterol, high density lipoprotein cholesterol 
(HDL) and log transformed glycosylated hemoglobin 
(HbA1c) was also seen in the Korean population. 
Susceptible polymorphism of IRS1 gene was reported 
to predispose risk towards T2DM (Ekrem et al. 2006; 
Kalliopi et al. 2010). Furthermore, findings in French, 
Danish and Finnish population-based cohorts revealed 
the C allele of rs2943641 near IRS1 was associated with 
fasting and glucose-stimulated hyperinsulinemia and also 
in impairment of insulin sensitivity (Ekrem et al. 2006). 
Taken everything together, whether these results showed 
the relevance of these findings where rs13306465 (IRS1) and 
rs328 (LPL) were significance with admission of neonates 
to NICU, need further verification. 
 The diagnosis of T2DM at six weeks post partum 
was detected with the presence of TCF7L2 gene where 
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TABLE 1. Risk factors and complications (n=288)
Risk factors & complications GDM 
n = 174 (%)
Controls
n = 114 (%)
Family history of diabetes mellitus
 Yes
 No
96 (55.2)
78 (44.8)
55 (48.2)
59 (51.8)
Uterus bigger than dates
 Yes 
 No
7 (4.0)
167 (96.0)
3 (2.7)
111 (97.3)
Glycosuria
 Yes
 No
17 (9.8)
157 (90.2)
9 (7.9)
105 (92.1)
Maternal complications
Premature delivery
 Yes
 No
30 (17.5)
141 (82.5)
21 (18.7)
91 (81.3)
Ceaserean section
 Yes
 No
48 (28.1)
123 (71.9)
35 (31.2)
77 (68.8)
Post partum diabetes (T2DM)
 Yes
 No
14 (31.8)
30 (68.2)
Fetal complication
Macrosomia (weight > 4kg)
 Yes
 No
11 (6.4)
160 (93.6)
3 (2.7)
109 (97.3)
Neonatal complications
Hyperbilirubinaemia
 Yes
 No
13 (7.6)
158 (92.4)
4 (3.6)
108 (96.4)
NICU admission
 Yes
 No
7 (4.3)
164 (95.7)
4 (3.6)
108 (96.4)
TABLE 2. Genetic relationship in risk factors and complications 
Parameter Gene SNPs Crude Odds ratio (95% CI) P value*
Family history of DM CDKAL1 rs10946398 0.49 (0.25,0.96) 0.006
Caesarean section LPL
OXTR
rs328
rs1042778
2.25 (1.07,4.73)
2.62 (1.28,5.36)
0.002
0.022
NICU Admission SLC2A2
SLC2A2
IRS1
rs5404
rs5400
rs13306465
6 (1.24,28.99)
4.84 (1.01,23.10)
5.68 (1.18,27.36)
0.028
0.033
0.031
Future T2DM TCF7L2
TCF7L2
TCF7L2
rs12255372
rs7901695
rs7903146
6.45 (2.05,20.34)
6.4 (2.04,20.07)
6.53 (2.04,20.83)
0.0004
0.0005
0.0005
*Trend test assessment
rs12255372, rs7901695 and rs7903146 were shown earlier 
to be associated with GDM in our pregnancy cohorts (Nor 
Khatijah et al. 2011). It was statistically proven that the 
presence of TCF7L2 variants were able to predict the risk of 
gestational diabetes mellitus as much as 1.89 to 2.20 times 
(odd ratio) as compared to the absence of these variants 
(Nor Khatijah et al. 2011), which was seen again in this 
current study with six times higher for T2DM. Furthermore 
previous GWA studies had shown consistent correlation 
between TCF7L2 and impairment of insulin secretion 
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in body (Saxena et al. 2007) and it was reproducibly 
associated with T2DM in various ethnic groups (Balding 
2006). GDM is regarded as a ‘window period’, a myth 
prior true features of T2DM is fully developed, currently 
is realised to play a significant role in halting genetic 
propagation if discovered earlier. Inquisition of remaining 
gaps between GDM and its genetic link has been highlighted 
in various parts of the world (Petry 2010). It is timely that 
this is further explored in the cohort of our patients.
CONCLUSION
The genetic factor for a multifactorial disease like GDM is 
complex. SNPS for genes CDKAL1, LPL, OXTR, SLC2A2, IRS1 
and TCF7L2 were discovered among pregnant Malaysian 
women with positive GDM risk factors and complications. 
Whether the presence of these SNPs in this study is just by 
chance or a true hallmark of a new finding warrants further 
scrutiny in a larger scale study. 
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